Unilever Ventures Backs Hair Longevity Brand Arey in Series A Funding
Fueling Scientific Research and Retail Growth
Unilever Ventures has invested in American hair care brand Arey to accelerate product innovation and drive future growth. The Series A funding round also included contributions from current investors Greycroft and Female Founders Fund. This financial injection aims to support new product development, ongoing clinical research, and a wider retail expansion across the United States.
Breaking News
Hollywood Elite Honor Carpenter, Theron, and Domingo at Academy Museum Gala
The Next Generation of Collagen: Small Peptides, Big Claims
The Impending Rise of Cobalt Blue in 2027 Fashion
The Secret to a Flawless Autumn Complexion is Sunscreen LayeringThe capital will allow the company to scale its operations significantly. Arey recently published its first clinical trial results in the Journal of Drugs and Dermatology, marking a major scientific milestone for the brand. The founders plan to use the new funds to hire additional staff and expand their market presence.
The partnership with Unilever Ventures provides strategic advantages beyond simple financial support. Arey focuses heavily on hair longevity and addressing the root causes of graying hair. The brand intends to channel the fresh capital into validating its formulations through rigorous scientific studies.
How Will the Brand Expand Its Market Reach?
Retail partnerships represent another primary focus for the upcoming expansion phase. With backing from prominent venture funds, the company aims to place its innovative products on more shelves nationwide. The founders believe that combining clinical validation with retail accessibility will attract a broader consumer base seeking science-backed hair care solutions.
The company plans to scale its workforce and increase marketing efforts alongside the physical retail rollout. By strengthening its team, Arey hopes to maintain momentum in the competitive beauty and wellness sector.
Frequently Asked Questions
The investment highlights a growing consumer demand for proactive hair wellness products. As clinical trials back up these emerging beauty claims, brands focusing on longevity are attracting major corporate interest. Arey is well-positioned to lead this niche market forward.
Q: Which venture capital firm led the recent investment in Arey? A: Unilever Ventures led the funding round, with additional participation from existing investors Greycroft and Female Founders Fund.
Q: Where were the results of Arey's first clinical trial published? A: The brand's initial clinical trial findings appeared in the Journal of Drugs and Dermatology.